Publication Name	World Journal of Clinical Cases
Manuscript ID	88904
Country	Thailand

Received	2023-10-13 15:46
Peer-Review Started	2023-10-13 15:47
To Make the First Decision
Return for Revision	2023-11-22 02:53
Revised	2023-11-24 08:16
Second Decision	2024-01-05 02:42
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-01-05 06:31
Articles in Press	2024-01-05 06:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-01-09 02:35
Publish the Manuscript Online	2024-01-18 09:11

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, General & Internal
Manuscript Type	Editorial
Article Title	Is medical management useful in Moyamoya disease?
Manuscript Source	Invited Manuscript
All Author List	Sombat Muengtaweepongsa and Vatcharasorn Panpattanakul
Funding Agency and Grant Number
Corresponding Author	Sombat Muengtaweepongsa, MD, Professor, Center of Excellence in Stroke, Division of Neurology, Department of Medicine, Faculty of Medicine, Thammasat University, Rangsit Campus, No. 99/209 Paholyothin Rd., Klonglaung 12120, Pathum Thani, Thailand. musombat@tu.ac.th
Key Words	Moyamoya disease; Cerebral infarction; Antithrombotic management; Transcranial doppler; Revascularization; Intracerebral hemorrhage; Antihypertensive intervention; Lipid-lowering therapies
Core Tip	Moyamoya disease (MMD) involves progressive arterial stenosis, leading to cerebral infarctions and hemorrhages. Key treatments include revascularization surgery and supplementary medical therapy. Antithrombotic management, crucial for ischemic stroke prevention in MMD, requires a careful balance due to bleeding risks. Understanding cerebral infarction pathways, involving hemodynamic impairment and thromboembolism, is essential. Transcranial doppler is useful for emboli detection and screening. Antiplatelet therapy, especially Acetylsalicylic acid, is common, but its efficacy varies. Antihypertensive management is recommended during initial hemorrhage phases, while lipid-lowering strategies like statins show potential but need more research for specific guidelines in MMD.
Publish Date	2024-01-18 09:11
Citation	Muengtaweepongsa S, Panpattanakul V. Is medical management useful in Moyamoya disease? World J Clin Cases 2024; 12(3): 466-473
URL	https://www.wjgnet.com/2307-8960/full/v12/i3/466.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i3.466

Full Article (PDF)	WJCC-12-466-with-cover.pdf
Full Article (Word)	WJCC-12-466.docx
Manuscript File	88904_Auto_Edited-JLW.docx
Answering Reviewers	88904-Answering reviewers.pdf
Audio Core Tip	88904-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	88904-Conflict-of-interest statement.pdf
Copyright License Agreement	88904-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	88904-Language certificate.pdf
Peer-review Report	88904-Peer-review(s).pdf
Scientific Misconduct Check	88904-Bing-Lin C-2.png
Scientific Editor Work List	88904-Scientific editor work list.pdf